Drug Interactions Expert Witnesses in Nevada

This fellowship-trained doctor received his medical doctorate from the University of Massachusetts School of Medicine. He completed a fellowship in Clinical Pediatric Hematology-Oncology at the prestigious University of Chicago Medical center. He is currently an assistant professor in the department of pediatrics hematology/oncology at a, where he frequently lectures on topics such as vascular abnormalities of the newborn.

This expert is a pharmacist and a pharmacologist and a former professor at Yale University and Georgetown University. He is also a former FDA Medical Officer/Senior Medical Analyst, who is an expert in the areas of drug Safety, drug development, regulatory affairs and FDA policy. He as also served as an advisor on the 2016 Ted Cruz presidential campaign, and has also been invited to testify in front of the U.S. Senate as a healthcare policy expert, FDA expert and Pharmacology expert. He has authored or co-authored over 50 publications, papers, articles, reviews, clinical protocols and reports in many related areas including FDA law, drug pricing, healthcare policy, healthcare insurance, drug development and drug patent law.

This highly qualified expert earned his Bachelor's degree in Chemistry from the University of California Riverside and his PhD in Comparative Pharmacology and Toxicology from the University of California San Francisco. A member of numerous pharmaceutical societies, he is extremely well published, having authored 120+ peer-reviewed papers and 10 books. He previously served as an Assistant Professor of pharmacology at Washington State University and the University of Southern California. This expert currently serves as an Associate Professor at a top university medical center in southern California.

This highly qualified expert earned his BS from George Fox University and PhD from University of California- Los Angeles. He completed a postdoctoral fellowship at The Scripps Research Institute. He is actively involved in research and education; to date he has 60+ original peer reviewed articles/ abstracts. Currently, he is an Assistant Professor of Pharmacology at a major university affiliated medical center. He has been trained in the study of drug discovery and taught on Molecular Pharmacology, Drug Discovery, Molecular Signaling/Transduction for the past few years at two medical schools. His research work includes collaborations with discovery teams to design new drug strategies, synthesize novel drugs, evaluate them in cell culture models, then evaluate their efficacy, side effect profiles, pharmacokinetics, and toxicology in animal models, all with the goal of developing new drugs for human treatment. Most of his research and drug development work is centered on developing new opioid and cannabinoid drugs for chronic pain, cancer treatment, and similar diseases.

This expert in Pharmaceutical R&D has worked with data confidentiality protocols from the perspective of both a leading research scientist and an industry consultant. He earned his PhD in Pharmaceutical Science following a BS in Pharmacy and a BS in Biology from the University of South Carolina. He is a member of multiple professional societies, has published multiple peer-reviewed manuscripts, and holds 4 patents in pharmaceutical technologies. The expert formerly served as a Senior Principal Scientist at Pfizer and as an Assistant Professor of Pharmacy at South University in Georgia. He currently serves as a pharmaceutical consultant for a private firm and as president of a second private consultancy in California.

This highly qualified expert has nearly three decades of experience in the field of pharmaceutical development. She received her BS in biochemistry and organic chemistry and both her DEA and PhD in medicinal chemistry, all from the University Louis Pasteur in Strasbourg, a prestigious French University. She holds 20 patents, mostly in relation to the processing and preparation of pharmaceuticals and is responsible for three finished products as well. She has held a variety of roles within the industry, beginning with several roles as a senior scientist and then moving up to principal scientist at ChemoCentryx, Inc. She then became a consultant for SciMed Partners and Franklin & Associates International LLC. She subsequently transitioned to working with patents, becoming a registered U.S. patent agent and then serving at both Wilson Sonsini Goodrich & Rosati and Morgan, Lewis & Bockius LLP. Currently, she is the founder and principal at a biopharmaceutical company and a co-founder and COO of a second biopharmaceutical company, both located in California.

This qualified expert pharmacist earned his PharmD from the University of the Pacific and continued to complete a residency at St. Joseph's Medical Center. He then earned his MS in organizational leadership at Southern New Hampshire University and his EdD from the higher education leadership from Aspen University. Today, he is a licensed registered pharmacist, with clinical certifications in geriatrics and psychiatry and remains active in his field as a member of the American Association of Colleges of Pharmacy, the American College of Clinical Pharmacy and the American Public Health Association. Formerly, this expert served as an assistant professor at the University of the Pacific and an associate professor at Roosevelt University and Manchester University, where he also has experience as the chair of the pharmacy practice. Additionally, he was the assistant dean of academic affairs and the chief diversity officer at Pacific University Oregon. Currently, this expert is a professor of pharmacy and an executive associate dean at a health sciences university in California.

This expert has over 30-years of experience in law enforcement, primarily with the Drug Enforcement Administration. He has written three criminal justice textbooks. He currently serves as a Criminal Justice consultant and expert witness with extensive experience in litigation support.